Shaping The Future Of Healthcare

Share

Impact of COVID-19 in Hospitals with Alexander Norbash, MD | Christoph Zindel

Season 1, Ep. 1

The current pandemic has made hospitals ground zero across the globe. If we haven’t personally been admitted into hospital by the virus, we can easily imagine scenes of medical staff rushing through crowded corridors, shuffling past one another, concealed head to toe in blue PPE anonymity. At some point over the past three months, this has been the daily reality in every hospital. <br>

<br>

How are hospitals managing during this unprecedented crisis? These are facilities well accustomed to “life or death” situations, but during a pandemic, downtime is a luxury that may never come. Yet, hospitals remain places of business that require management. Particularly in times of crisis, faculty need motivation to push on, and good leadership is more important than ever. University hospitals have the added challenge of overseeing a student population. Today, we’re getting a glimpse of what this crisis has been like from inside one of the top ranked University hospitals in the world. 

Our guest is Alexander Norbash, MD, an Interventional Neuroradiologist from the University of California, San Diego, where he is the Chair and Professor of Radiology, and the Associate Vice Chancellor. There, his focus is on arteriovenous vascular malformations and intracranial aneurysms, and he was among the first clinician-interventionalists to develop and describe the technology of stenting for the carotid and intracranial arteries. Dr. Christoph Zindel is Member of the Managing Board of Siemens Healthineers and holds a Doctor of Medicine M.D.

SOME QUESTIONS WE ASK:

  • How is the current situation affecting you? (3:40)
  • How do you deal with this crisis on the University level? (6:01)
  • Do you have a crisis management process in place for these situations? (10:18)
  • How are you preparing for patients coming back?(16:31)
  • How is the pandemic shaping your research? (22:57)
  • What can healthcare learn from this pandemic? (31:05)

IN THIS EPISODE, YOU WILL LEARN:

  • How people find opportunity during times of crisis (2:23)  
  • How the crisis has affected the University financially (8:12)
  • How to keep people motivated and morale high/ or The Importance of Gratitude (13:31)
  • The biggest current challenge facing this border region (20:44)
  • How diversity and inclusion are being addressed (tele-visits can be an equalizer) (27:13)

Learn more about Alexander Norbash, MD:

UCSD Profile: https://profiles.ucsd.edu/alexander.norbash

Publications: https://www.pubfacts.com/author/Alexander+Norbash

Scholar Citations: https://scholar.google.com/citations?user=rQYPnAcAAAAJ&hl=en

Head Injury Institute: http://www.headinjuryinstitute.org/about-us/leadership/alexander-norbash-md-mhcm-facr/

More Episodes

9/15/2021

Integrated Diagnostics and the Collaborative Future of Medicine with Prof. Dr. Stefan Schönberg | Christoph Zindel

Season 1, Ep. 14
One of the biggest beneficiaries of technological advancements has been the field of medicine. While vaccines to stop previous pandemics took decades to develop, multiple COVID-19 vaccines were developed within a much shorter time frame. Increased collaboration between players in the industry and those in the tech world promises even more advancements in the near future.In this episode, Managing Board Member Christoph Zindel is joined by Stefan Schönberg, MD, director and chairman of the department of radiology and nuclear medicine at the University Medical Center Mannheim. He is former President of the German Roentgen Society and a strong proponent of integrated diagnostics.In today’s conversation, you’ll hear about integrated diagnostics and the benefits that come with it. You’ll learn about the advancements that are being made and the existing gaps that need to be closed to take the medical industry to the next level. You’ll also learn about the role that AI has in advancing diagnostics, treatment, and prevention of diseases. Lastly, we’ll discuss the role of data in medical research and the current barriers to federated learning and research.Some Questions Asked:Can you give us a glimpse of integrated diagnostics at University Hospital in Mannheim? (01:11)Do you see circulating free DNA being used in early cancer detection? (08:39)Do you believe that integrated diagnostic influences therapeutic decisions? (12:33)How do you promote cultural change connected to integrated diagnostics? (21:45)What You’ll Learn in This Episode:How integrated diagnostic can be used to understand a disease’s trajectory (05:56)What is needed to make integrated diagnostic a success (11:01)The role of the digital twin in integrated diagnostics (16:31)How federated learning evidence can accelerate medical research (18:58)Connect with Prof. Dr. Stefan Schönberg:University Hospital MannheimConnect with our Managing Board Member, Christoph Zindel:LinkedIn
7/20/2021

The Importance of Radiology in Developing Nations with Dr. Suresh de Silva | Christoph Zindel

Season 1, Ep. 13
Economic disparities around the world are an unfortunate reality. The past year has made it clearer than ever that the availability of quality healthcare for everyone benefits the whole. Globalization has forged a connection that strengthens our sense of humanity. With that sentiment in mind, it’s important that those who can help recognize that they bear a responsibility to lift up the whole.In this episode, Managing Board Member Christoph Zindel talks to Dr. Suresh de Silva, founder of Radiology Across Borders, a global charity that provides education and programs in radiology to help save lives in developing nations. Dr. de Silva is a fellow of the Royal Australian and New Zealand College of Radiologists and also an Adjunct Senior Lecturer at UNSW and an Oncological/Urological radiologist.In today’s conversation, you’ll hear about the positive global impact of Dr. Suresh de Silva’s organization, Radiology Across Borders. Their numerous projects are helping not only with treatment, but also with screening and prevention in populations that need greater access to medical technology and care. You’ll also hear important perspectives on the impact and future possibilities of AI in medical care. Additionally, the conversation covers the realities of starting a global charity from the ground up, and delves into the mindset of a founder who has successfully made an impact on countless lives around the world.Some Questions Asked:What projects are you currently focused on? (9:21)What's your vision of the role of AI-supported radiology in the future? (17:43)How can other organizations learn from Radiology Across Borders? (26:27)How have you been affected privately and professionally by this pandemic? (34:56)What You’ll Learn in This Episode:The important role radiology plays in healthcare (4:52)The biggest potential impact of AI (20:51)The realities of creating a charity organization (29:15)Comparing the differences between recent pandemics (37:20)Connect with Dr. Suresh de Silva:LinkedInConnect with our Managing Board Member, Christoph Zindel:LinkedIn
5/5/2021

How Do Coronavirus Variants Affect our Immune System, and How Can We Protect our Vulnerable?

Season 1, Ep. 12
We’ve come a long way in our understanding of SARS-CoV-2. Since the first cases were reported in late 2019, the rapid spread of the virus required quick thinking, thorough communication across the globe, and immediate action within the medical community. SARS-CoV-2 spread rapidly and began mutating differently all over the world. Tracking, testing, and treatment options had to keep pace. We needed information quickly in order to treat people effectively and protect our most vulnerable.Today, Siemens Healthineers President of Laboratory Diagnostics, Deepak Nath is joined by Dr. Ankur Mutreja, a global health scientist from the University of Cambridge, and Dr. Kevin Latinis, a clinical Rheumatologist with a practice in Missouri. Their experiences throughout the SARS-CoV-2 outbreak will help us understand how the virus continues to mutate globally, why viruses mutate, and how early antibody testing helped us to understand the ability of this virus to spread at such an advanced pace.In this episode, you’ll hear about the known variants of SARS-CoV-2, how our immune systems respond through these mutations, and why names matter. We’ll also rewind back to the beginning of the pandemic and hear about some of the earliest serology tests that took place in a Missouri nursing home, and how that timely information helped us understand how the virus spread.Some Questions Asked:What consequences can naming variants after countries or regions have? (2:09)Could a new variant emerge that effectively sets us back to square one? (4:14)How can vaccine development keep pace with these variants? (9:13)Why use antibody tests? (15:18)How can we take care of our most vulnerable? (19:49)What are the next steps for data collection? (22:39)What You’ll Learn in This Episode:Why new variants of the virus continue to be discovered (2:59)Protection levels against new variants from antibodies and the vaccine (4:54)Why mutations occur and when we need to be concerned about them (5:51)What we learned from an early study of antibodies (14:23)How antibody tests work, and what they can tell us (17:30)How one doctor is helping patients feel comfortable with vaccines (21:02)Connect with Ankur Mutreja:LinkedInConnect with Kevin Latinis:LinkedInYoutubeConnect with Katherine Soreng:LinkedInConnect with Deepak Nath:LinkedInTwitter